180 Historical Balance Sheet

ATNF Stock

USD 1.44 0.03 2.13%

Trend analysis of 180 Life Sciences balance sheet accounts such as Total Current Liabilities of 8.6 M, Other Assets of 0.0 or Cash And Short Term Investments of 1.7 M provides information on 180 Life's total assets, liabilities, and equity, which is the actual value of 180 Life Sciences to its prevalent stockholders. By breaking down trends over time using 180 Life balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining 180 Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether 180 Life Sciences is a good buy for the upcoming year.

180 Life Inventory

(530,930)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About 180 Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of 180 Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. 180 Life Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of 180 Life and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which 180 currently owns. An asset can also be divided into two categories, current and non-current.

180 Life Balance Sheet Chart

At this time, 180 Life's Short Term Debt is most likely to increase significantly in the upcoming years. The 180 Life's current Other Current Liabilities is estimated to increase to about 4.6 M, while Total Stockholder Equity is forecasted to increase to (139.5 K).

Total Assets Total Current Liabilities Cash And Short Term Investments Capital Surpluse

Add Fundamental

Total Assets

Total assets refers to the total amount of 180 Life assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in 180 Life Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on 180 Life balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of 180 Life Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of 180 Life Sciences balance sheet. This account contains 180 Life investments that will expire within one year. These investments include stocks and bonds that can be liquidated by 180 Life Sciences fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most accounts from 180 Life's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into 180 Life Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Total Current Liabilities	5.7M	5.1M	5.8M	8.6M
Total Assets	19.7M	5.3M	4.7M	4.5M

Total Current Liabilities Total Assets

180 Life balance sheet Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Cash And Short Term Investments	Capital Surpluse	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Current Liab	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Net Tangible Assets	Accounts Payable	Net Receivables	Other Current Assets	Property Plant Equipment	Short Long Term Debt Total	Other Liab
Total Assets		0.25	0.45	0.14	0.88	0.64	0.4	0.11	0.87	0.85	0.22	0.02	0.07	0.1	-0.03	0.17	-0.03	0.26	-0.06	-0.06	0.15	0.17	-0.02	0.04	0.19	0.21
Total Current Liabilities	0.25		0.82	-0.5	-0.19	0.57	0.98	0.71	0.52	-0.25	0.79	-0.17	0.62	-0.57	-0.8	0.64	-0.78	-0.19	0.61	0.46	0.75	0.91	0.53	0.75	-0.27	-0.14
Total Stockholder Equity	0.45	0.82		-0.17	-0.04	0.48	0.85	0.52	0.63	-0.08	0.68	-0.05	0.46	-0.28	-0.56	0.41	-0.56	0.19	0.37	0.35	0.58	0.67	0.3	0.57	0.02	0.22
Retained Earnings	0.14	-0.5	-0.17		0.27	-0.65	-0.47	-0.72	-0.13	0.3	-0.43	0.37	-0.64	0.98	0.9	-0.08	0.9	0.89	-0.96	-0.89	-0.37	-0.57	-0.78	-0.87	0.93	0.57
Cash And Short Term Investments	0.88	-0.19	-0.04	0.27		0.43	-0.04	-0.16	0.62	1.0	-0.13	0.04	-0.17	0.28	0.28	-0.06	0.29	0.22	-0.28	-0.26	-0.18	-0.19	-0.19	-0.28	0.21	0.14
Capital Surpluse	0.64	0.57	0.48	-0.65	0.43		0.66	0.57	0.79	0.39	0.42	-0.14	0.46	-0.69	-0.72	0.23	-0.73	-0.49	0.69	0.63	0.46	0.54	0.53	0.73	-0.54	-0.29
Total Liab	0.4	0.98	0.85	-0.47	-0.04	0.66		0.7	0.65	-0.1	0.77	-0.16	0.61	-0.55	-0.78	0.62	-0.76	-0.16	0.59	0.45	0.74	0.9	0.49	0.73	-0.24	-0.14
Total Current Assets	0.11	0.71	0.52	-0.72	-0.16	0.57	0.7		0.2	-0.23	0.83	-0.77	0.98	-0.7	-0.8	0.14	-0.76	-0.39	0.75	0.71	0.26	0.83	0.87	0.75	-0.71	-0.23
Short Term Debt	0.87	0.52	0.63	-0.13	0.62	0.79	0.65	0.2		0.59	0.25	0.22	0.11	-0.23	-0.38	0.43	-0.39	0.03	0.24	0.17	0.57	0.42	0.02	0.37	0.07	0.03
Common Stock	0.85	-0.25	-0.08	0.3	1.0	0.39	-0.1	-0.23	0.59		-0.18	0.08	-0.23	0.32	0.34	-0.11	0.34	0.22	-0.32	-0.29	-0.22	-0.25	-0.23	-0.32	0.24	0.14
Other Current Liab	0.22	0.79	0.68	-0.43	-0.13	0.42	0.77	0.83	0.25	-0.18		-0.59	0.81	-0.42	-0.61	0.14	-0.58	-0.14	0.54	0.52	0.19	0.72	0.78	0.55	-0.4	-0.16
Net Debt	0.02	-0.17	-0.05	0.37	0.04	-0.14	-0.16	-0.77	0.22	0.08	-0.59		-0.85	0.26	0.28	0.29	0.21	0.14	-0.32	-0.38	0.36	-0.4	-0.71	-0.21	0.56	0.06
Cash	0.07	0.62	0.46	-0.64	-0.17	0.46	0.61	0.98	0.11	-0.23	0.81	-0.85		-0.61	-0.71	0.05	-0.65	-0.3	0.67	0.65	0.13	0.78	0.83	0.63	-0.66	-0.21
Non Current Assets Total	0.1	-0.57	-0.28	0.98	0.28	-0.69	-0.55	-0.7	-0.23	0.32	-0.42	0.26	-0.61		0.94	-0.16	0.95	0.86	-0.98	-0.9	-0.49	-0.62	-0.72	-0.91	0.86	0.58
Non Currrent Assets Other	-0.03	-0.8	-0.56	0.9	0.28	-0.72	-0.78	-0.8	-0.38	0.34	-0.61	0.28	-0.71	0.94		-0.34	1.0	0.65	-0.95	-0.84	-0.64	-0.81	-0.72	-0.97	0.73	0.41
Common Stock Shares Outstanding	0.17	0.64	0.41	-0.08	-0.06	0.23	0.62	0.14	0.43	-0.11	0.14	0.29	0.05	-0.16	-0.34		-0.31	0.08	0.06	-0.21	0.87	0.6	-0.14	0.32	0.2	0.12
Short Term Investments	-0.03	-0.78	-0.56	0.9	0.29	-0.73	-0.76	-0.76	-0.39	0.34	-0.58	0.21	-0.65	0.95	1.0	-0.31		0.67	-0.95	-0.86	-0.64	-0.76	-0.7	-0.97	0.72	0.43
Non Current Liabilities Total	0.26	-0.19	0.19	0.89	0.22	-0.49	-0.16	-0.39	0.03	0.22	-0.14	0.14	-0.3	0.86	0.65	0.08	0.67		-0.81	-0.75	-0.18	-0.22	-0.61	-0.63	0.86	0.76
Other Stockholder Equity	-0.06	0.61	0.37	-0.96	-0.28	0.69	0.59	0.75	0.24	-0.32	0.54	-0.32	0.67	-0.98	-0.95	0.06	-0.95	-0.81		0.96	0.41	0.63	0.8	0.92	-0.87	-0.58
Net Tangible Assets	-0.06	0.46	0.35	-0.89	-0.26	0.63	0.45	0.71	0.17	-0.29	0.52	-0.38	0.65	-0.9	-0.84	-0.21	-0.86	-0.75	0.96		0.19	0.46	0.81	0.83	-0.86	-0.52
Accounts Payable	0.15	0.75	0.58	-0.37	-0.18	0.46	0.74	0.26	0.57	-0.22	0.19	0.36	0.13	-0.49	-0.64	0.87	-0.64	-0.18	0.41	0.19		0.68	0.01	0.62	-0.03	-0.07
Net Receivables	0.17	0.91	0.67	-0.57	-0.19	0.54	0.9	0.83	0.42	-0.25	0.72	-0.4	0.78	-0.62	-0.81	0.6	-0.76	-0.22	0.63	0.46	0.68		0.53	0.71	-0.37	-0.22
Other Current Assets	-0.02	0.53	0.3	-0.78	-0.19	0.53	0.49	0.87	0.02	-0.23	0.78	-0.71	0.83	-0.72	-0.72	-0.14	-0.7	-0.61	0.8	0.81	0.01	0.53		0.72	-0.87	-0.38
Property Plant Equipment	0.04	0.75	0.57	-0.87	-0.28	0.73	0.73	0.75	0.37	-0.32	0.55	-0.21	0.63	-0.91	-0.97	0.32	-0.97	-0.63	0.92	0.83	0.62	0.71	0.72		-0.72	-0.31
Short Long Term Debt Total	0.19	-0.27	0.02	0.93	0.21	-0.54	-0.24	-0.71	0.07	0.24	-0.4	0.56	-0.66	0.86	0.73	0.2	0.72	0.86	-0.87	-0.86	-0.03	-0.37	-0.87	-0.72		0.53
Other Liab	0.21	-0.14	0.22	0.57	0.14	-0.29	-0.14	-0.23	0.03	0.14	-0.16	0.06	-0.21	0.58	0.41	0.12	0.43	0.76	-0.58	-0.52	-0.07	-0.22	-0.38	-0.31	0.53

Click cells to compare fundamentals

180 Life Account Relationship Matchups

180 Life balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	55.5M	62.7M	19.7M	5.3M	4.7M	4.5M
Total Current Liabilities	21.4M	19.7M	5.7M	5.1M	5.8M	8.6M
Total Stockholder Equity	30.3M	39.3M	11.3M	(127.7K)	(146.9K)	(139.5K)
Retained Earnings	(48.4M)	(68.7M)	(107.4M)	(127.3M)	(114.6M)	(108.9M)
Total Liab	25.2M	23.4M	8.3M	5.4M	6.2M	11.6M
Total Current Assets	4.0M	11.2M	8.9M	3.6M	4.2M	4.0M
Short Term Debt	3.7M	1.9M	1.3M	1.0M	930.7K	1.5M
Common Stock	2.6K	3.4K	375.0	54.0	48.6	46.17
Other Current Liab	4.4M	17.2M	2.5M	2.1M	2.5M	4.6M
Net Debt	1.7M	(6.3M)	(5.6M)	(921.7K)	(829.6K)	(871.0K)
Cash	2.1M	8.2M	7.0M	2.0M	2.3M	3.2M
Non Current Assets Total	51.5M	51.5M	10.7M	1.6M	1.5M	1.4M
Common Stock Shares Outstanding	18.2M	82.5K	100.0K	379.1K	436.0K	414.2K
Liabilities And Stockholders Equity	25.2M	62.7M	19.7M	5.3M	4.7M	4.5M
Non Current Liabilities Total	3.8M	3.7M	2.6M	324.6K	292.1K	277.5K
Other Stockholder Equity	636.9K	107.2M	121.6M	130.1M	149.6M	157.1M
Accounts Payable	8.5M	586.6K	1.8M	1.9M	1.7M	2.3M
Net Receivables	784.6K	694.6K	621.0K	279.0K	320.9K	535.8K
Other Current Assets	14.4K	3.0M	1.3M	1.7M	1.9M	1.1M
Short Long Term Debt Total	3.8M	2.0M	1.3M	1.1M	948.7K	1.9M
Net Invested Capital	34.1M	41.3M	12.7M	926.3K	833.7K	792.0K
Short Long Term Debt	3.7M	1.9M	1.3M	1.0M	930.7K	1.8M
Accumulated Other Comprehensive Income	636.9K	817.4K	(2.9M)	(2.9M)	(2.6M)	(2.5M)
Capital Stock	2.6K	3.4K	375.0	54.0	48.6	46.17
Net Working Capital	(17.4M)	(8.5M)	3.3M	(1.4M)	(1.6M)	(1.7M)
Intangible Assets	14.6M	14.5M	10.7M	1.6M	1.5M	1.4M

Currently Active Assets on Macroaxis

F	Ford Motor
GM	General Motors
S	SentinelOne
GOOG	Alphabet Inc Class C
WD	Walker Dunlop

When determining whether 180 Life Sciences is a strong investment it is important to analyze 180 Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 180 Life's future performance. For an informed investment choice regarding 180 Stock, refer to the following important reports:

How To Invest In 180

Details

Is 180 Stock a good investment?

Details

What is 180 Life's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

7.98

Return On Assets

(0.64)

Return On Equity

(3.99)

The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

180 Historical Balance Sheet

180 Life Inventory

(530,930)

About 180 Balance Sheet Analysis

180 Life Balance Sheet Chart

Total Assets

Total Current Liabilities

Cash And Short Term Investments

180 Life balance sheet Correlations

180 Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

180 Life balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Cash And Short Term Investments
Short Term Investments	+ 1.0	Non Currrent Assets Other
Total Liab	+ 0.98	Total Current Liabilities
Non Current Assets Total	+ 0.98	Retained Earnings
Cash	+ 0.98	Total Current Assets
Net Tangible Assets	+ 0.96	Other Stockholder Equity

Other Stockholder Equity	- 0.98	Non Current Assets Total
Property Plant Equipment	- 0.97	Short Term Investments
Property Plant Equipment	- 0.97	Non Currrent Assets Other
Other Stockholder Equity	- 0.96	Retained Earnings
Other Stockholder Equity	- 0.95	Short Term Investments
Other Stockholder Equity	- 0.95	Non Currrent Assets Other